Top Trends Transforming the Virology Testing Market Landscape in 2025: Virology Testing Market Embraces Product Innovation For Enhanced Diagnostic Capabilities

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Virology Testing Industry Market Size Be by 2025?
In recent times, the size of the virology testing market has shown powerful growth. It's projected to escalate from $5.39 billion in 2024 to $5.86 billion in 2025, expanding at a compound annual growth rate (CAGR) of 8.6%. Factors such as the advent of new and intricate viruses, rise in outbreaks of infectious diseases, enlargement of healthcare infrastructure, heightened awareness about the significance of early virus detection, and an increase in point-of-care virology testing options are contributing to this unprecedented growth during the historical period.

What's the Long-Term Growth Forecast for the Virology Testing Market Size Through 2029?
The market size of virology testing is predicted to witness significant expansion in the forthcoming years, raising the worth to $8.82 billion by 2029, with a compound annual growth rate (CAGR) of 10.8%. This surge during the prediction period is due to factors such as the incorporation of next-generation sequencing in virology, the climatic change's impulse on spreading vector-borne viruses, the emergence of mobile and home-based virology testing services, adoption of digital pathology in virology diagnostics, and the expanded use of big data analytics in virology surveillance. The forecast period will also observe major progressions such as cutting-edge developments in molecular diagnostics, the inclusion of artificial intelligence in virology testing, the creation of innovative virus detection biomarkers, the development of new antiviral therapies and treatments, and focus on sustainable and environmentally friendly testing procedures.

View the full report here:
https://www.thebusinessresearchcompany.com/report/virology-testing-global-market-report

What Are the Key Growth Drivers Fueling the Virology Testing Market Expansion?
The escalating occurrence of viral infections worldwide is predicted to fuel the expansion of virology testing market in the future. These infections, caused by viruses, are microscopic infectious agents comprised of genetic structure enveloped in a protein layer and are known to provoke infectious diseases. The need for virology testing is crucial in guaranteeing an accurate diagnosis, tracking, research, and readiness in public health. It also fosters the detection of viral pathogens, instructs treatment methods, monitors the spread of infections, and contributes to the formulation of new interventions. The growth in demand for virology testing arises from the requirement to efficiently handle these infections and minimize their adverse effects. To exemplify, a report from GOV.UK, a UK-based government services and data supplier, in September 2024 revealed that out of the virology test results available between the 40th week of 2023 and the 14th week of 2024 in England, 708 incidents (53.3%) were confirmed as SARS-CoV-2. This was followed by 472 incidents of influenza (35.5%), 68 incidents of RSV (5.1%), and 80 incidents (6.0%) involving other viruses. As a result, the upsurging incidence of viral infections is stimulating the advancement of the virology testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12531&type=smp

What Are the Key Trends Driving Virology Testing Market Growth?
Trend 1:

The emergence of product innovation is a defining trend in the virology testing market. Major players in the market are spearheading new product development to maintain their status. For example, in November 2022, Sentinel CH. SpA, an Italian medical device manufacturing company, introduced SENTiNAT 200, a highly automated system that goes from sample to result, along with the STAT-NAT SN200 Real-Time PCR assays for the precise detection of ten viruses. The SENTiNAT 200 platform merges DNA and RNA extraction, PCR setup, and amplification, incorporating two thermal cyclers, and the FastFinder analytical software. It provides efficiency, automation, and adaptability for medium to large scale laboratories engaged in diagnosing viral infections. Its user-friendly software and barcode reader diminish human errors, whereas the ability to access data through the cloud enhances reporting time and control over results.

How Is the Virology Testing Market Segmented?
The virology testing market covered in this report is segmented -

1) By Type: Instruments, Assay Kits And Consumables
2) By Diagnostic Technique: Molecular Diagnostics Method, Immunoassay Based Method, Mass Spectroscopy Based Method, Other Techniques
3) By Application: Skin And Soft Tissue Infections, Respiratory Tract Infections, Gastrointestinal Tract Infections, Urinary Tract Infection, Eye Infections, Sexually Transmitted Diseases, Perinatal Infections
4) By End User: Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, Pharmacies

Subsegments:
1) By Instruments: PCR Machines, Sequencers, Microplate Readers, Immunoassay Analyzers
2) By Assay Kits And Consumables: PCR Assay Kits, ELISA Kits, Rapid Test Kits, Viral Culture Kits, Sample Collection Kits, Pipette Tips, Culture Media

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12531&type=smp

Which Companies Are Leading the Charge in Virology Testing Market Innovation?
Major companies operating in the virology testing market include Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Boehringer Ingelheim International GmbH, Siemens Healthineers AG, Eurofins Scientific SE, Agilent Technologies Inc., Grifols S.A., WuXi AppTec Co. Ltd., Hologic Inc., Sartorius AG, bioMerieux SA, Bio-Rad Laboratories Inc., Qiagen NV, Cepheid Inc, Eiken Chemical Co Ltd., DiaSorin SpA, Fujirebio Diagnostics Inc., Microbac Laboratories Inc., Trinity Biotech plc, Diamedix Corporation, Biospherix Ltd, Imquest Biosciences Inc, Novogene Co Ltd., Scienion AG, Vircell SL

Which Regions Are Leading the Global Virology Testing Market in Revenue?
North America was the largest region in the virology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12531

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.